NOBIVAC SOLVENT
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
06-01-2016
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Intervet Ireland Limited
ATC code:
QV07AB
Dosage:
%v/v
Pharmaceutical form:
Solvent for Parenteral Use
Prescription type:
POM
Therapeutic group:
Canine, Feline
Therapeutic area:
Solvents and diluting agents, incl. irrigating solutions
Therapeutic indications:
Immunological - Diluent
Authorization status:
Authorised
Authorization date:
2003-10-03
Summary of Product characteristics
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Nobivac Solvent
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCES:
None
EXCIPIENTS:
For the full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solvent for parenteral use.
Clear, colourless liquid.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Solvent for reconstitution of Nobivac DHP, Nobivac DHPPi, Nobivac Parvo-C, Nobivac Ducat and Nobivac Tricat
Trio vaccines.
4.3 CONTRAINDICATIONS
Any contra-indications specified for the vaccine for which the solvent is used for reconstitution will apply.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
There are no special warnings, however any warnings specified for the vaccine for which Nobivac Solvent is used as
the solvent will apply.
4.5 SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
No special precautions are required for handling the solvent however any recommendations specified for the vaccine
for which Nobivac Solvent is used as a solvent will apply.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the
physician.
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 22/12/2015_
_CRN 7022473_
_page number: 1_
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Any adverse effects specified for the vaccine for which Nobivac Solvent is used as the solvent will apply.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Any recommendations specified for the vaccine for which Nobivac Solvent is used as the solvent
Read the complete document
